Platelet-to-Lymphocyte Ratio Calculator
Calculate platelet-to-lymphocyte ratio from matched absolute blood counts with exact unit normalization and nonspecific interpretation limits.
Content updated: View sources
QuickMedCalc is developed and maintained by an independent developer. Medical content is not independently reviewed by a physician.
Formula and medical content are based on the references listed on this page. See sources, About, and Sources and Review Process.
About
Formula
Interpretation
What the result represents
PLR is a unitless arithmetic quotient of two contemporaneous absolute blood counts. It does not identify why either count is high or low.
Input units
Either count may use ×10³/µL, the numerically equivalent ×10⁹/L, or cells/µL. Both values are normalized to cells/µL exactly before division. Percent lymphocytes are excluded.
Worked example — not a result classification
| Platelets | Absolute lymphocytes | Arithmetic PLR |
|---|---|---|
| 250 ×10³/µL | 2 ×10³/µL | 125 |
| 250 ×10⁹/L | 2,000 cells/µL | 125 |
Applicable population and study-specific context — not calculated
A four-center western-China study reported age- and sex-associated PLR variation in 5,969 healthy Han Chinese adults. Pediatric PLR distributions vary by age and sex, and pregnancy PLR can vary by trimester. Healthy-adult intervals cannot be applied automatically to pediatric or pregnancy assessments. Rheumatology, oncology, cardiovascular, and sepsis studies use different populations, methods, collection times, endpoints, and thresholds. These adult, pediatric, pregnancy, and disease-study findings cannot be converted into a universal interval or applied automatically to this result.
Interpretation limitations
Review the source CBC, differential, laboratory intervals, collection time, medicines, infection/inflammation, immune status, hematologic conditions, bleeding or thrombosis context, and the applicable clinical pathway. A single PLR cannot diagnose or exclude disease, determine prognosis, or select testing, referral, medication, or treatment.
References
- Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019;39(4):345–357. PMID 30809980. PMCID PMC6400713. DOI 10.3343/alm.2019.39.4.345.
- Luo H, et al. Normal Reference Intervals of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: a Large Multi-Center Study from Western China. Clin Lab. 2019;65(3). PMID 30868857. DOI 10.7754/Clin.Lab.2018.180715.
- Templeton AJ, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204–1212. PMID 24793958. DOI 10.1158/1055-9965.EPI-14-0146.
- Peng HX, et al. Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis. FEBS Open Bio. 2016;6(7):742–750. PMID 27398314. PMCID PMC4932454. DOI 10.1002/2211-5463.12083.
- Wang G, et al. Prognostic Value of Platelet to Lymphocyte Ratio in Sepsis: A Systematic Review and Meta-analysis. Biomed Res Int. 2022;2022:9056363. PMID 35707370. PMCID PMC9192240. DOI 10.1155/2022/9056363.
- Moosmann J, et al. Age- and sex-specific pediatric reference intervals for neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio. Int J Lab Hematol. 2022;44(2):296–301. PMID 34816610. DOI 10.1111/ijlh.13768.
- Hershko Klement A, et al. Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: A population study. PLoS One. 2018;13(5):e0196706. PMID 29787560. PMCID PMC5963784. DOI 10.1371/journal.pone.0196706.
FAQ
Divide an absolute platelet count by an absolute lymphocyte count after putting both counts on the same scale. The result is unitless.
No. It uses an absolute lymphocyte count. A percentage cannot be divided into an absolute platelet count without another count, so this calculator does not accept that mixture.
Platelets and lymphocytes can change over time. Combining unrelated collection times can create a quotient that never represented one CBC and differential.
Each absolute count can use ×10³/µL, the numerically equivalent ×10⁹/L, or cells/µL. The calculator normalizes both values exactly before division.
A real unit change would otherwise reinterpret the same number on a different scale. Clearing the value requires the source report to be checked again.
Zero is accepted as an arithmetic numerator and produces a true PLR of zero when the absolute lymphocyte denominator is positive. The source laboratory result and its clinical urgency still require review.
The absolute lymphocyte count is the denominator. Division by zero is undefined, so a quotient cannot be produced for a zero or missing denominator.
No. Findings vary by disease, population, laboratory setting, treatment, collection timing, endpoint, and selected cutoff. This page assigns no universal category.
A four-center study of 5,969 healthy Han Chinese adults in western China reported age- and sex-associated PLR variation and study-specific intervals. Those results are population evidence, not a universal calculator range.
Not automatically. Pediatric PLR distributions vary by age and sex. Adult, pediatric, pregnancy, and disease-study results are population- and method-specific, and this page does not apply a dynamic interval or low, normal, high, positive, or negative category to a result.
Yes. PLR can vary by trimester in pregnancy. A healthy-adult study interval should not be transferred automatically to pregnancy, and this page does not provide pregnancy-specific diagnosis, exclusion, prognosis, or treatment classification.
No. Platelets and lymphocytes change for many reasons. PLR is nonspecific and cannot establish or exclude inflammation, infection, sepsis, or another diagnosis.
No. Oncology studies and meta-analyses use different cancers, stages, treatments, timings, outcomes, and cutoffs. A quotient alone does not diagnose cancer or provide an individualized prognosis.
Yes. Corticosteroids, immunosuppressive treatment, chemotherapy, platelet-active treatment, and other medicines can affect one or both counts. Interpretation requires the source results and medication context.
Yes. Collection timing, specimen quality, analyzer methods, reporting conventions, and selection of the study population can affect the component counts and published PLR evidence.
No. PLR uses platelets and lymphocytes; NLR uses neutrophils and lymphocytes; SII uses platelets multiplied by neutrophils and divided by lymphocytes. Their evidence and units are not interchangeable.
No. It does not order repeat blood counts, cultures, imaging, referral, medication, dose, admission, transfusion, anticoagulation, chemotherapy, or another treatment.
Related Calculators
NLR
Calculate NLR from matched absolute counts or percentages with exact decimal arithmetic and neutral interpretation limits.
ANC
Calculate ANC from same-CBC WBC, segmented neutrophils, and separately reported bands with explicit units and neutral limits.
Age-Adjusted ESR
Reproduce the Miller 1983 source-cohort ESR upper-limit estimate for ages 20–65 using one explicit historical formula, with laboratory-method limitations.
Disclaimer
Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.